Cargando…

Lipoprotein (a) and coronary heart disease – is there an efficient secondary prevention?

Lipoprotein (a) (Lp (a)) is one risk factor for the development of cardiovascular diseases. Several studies have shown that Lp (a) hyperlipoproteinaemia has a particular influence on the development of coronary heart disease (CHD). A retrospective single-centre observation study was performed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mellwig, Klaus-Peter, Horstkotte, Dieter, van Buuren, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352755/ https://www.ncbi.nlm.nih.gov/pubmed/28233270 http://dx.doi.org/10.1007/s11789-017-0088-x

Ejemplares similares

Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease
por: van Buuren, Frank, et al.
Publicado: (2017)

HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures
por: Buuren, Frank van, et al.
Publicado: (2012)

Lipid apheresis: oxidative stress, rheology, and vasodilatation
por: Mellwig, K.-P., et al.
Publicado: (2012)

Marked Regression of Left Ventricular Hypertrophy after Outflow Desobliteration in HOCM
por: Dimitriadis, Zisis, et al.
Publicado: (2012)

Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022)

Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease
por: Nidorf, Stefan M, et al.
Publicado: (2022)

Editorial Lp(a) – the underestimated cardiovascular risk factor
por: Mellwig, Klaus-Peter
Publicado: (2017)

Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease
por: Kokubo, Yoshihiro, et al.
Publicado: (2020)

Association of lipoprotein lipase gene with coronary heart disease in Sudanese population
por: Abdel Hamid, Muzamil M., et al.
Publicado: (2015)

Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention
por: Feng, Can, et al.
Publicado: (2017)

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
por: Joshi, Parag H., et al.
Publicado: (2016)

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
por: Björnson, Elias, et al.
Publicado: (2023)

Lifestyle Behaviors Associated With Secondary Prevention of Coronary Heart Disease Among California Adults
por: Bellow, Andrew, et al.
Publicado: (2011)

Lifestyle changes in secondary prevention of coronary heart disease: breaking the chains of unhealthy habits
por: Peters, R. J. G.
Publicado: (2013)

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
por: Yamashita, Shizuya, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients
por: Hu, Ziyang, et al.
Publicado: (2021)

Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women
por: Perrella, Joel, et al.
Publicado: (2003)

Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data
por: Mathews, Simon C., et al.
Publicado: (2012)

Lipoprotein(a) and Coronary Artery Disease Risk Without a Family History of Heart Disease
por: Finneran, Phoebe, et al.
Publicado: (2021)

Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists
por: Ferrières, Jean, et al.
Publicado: (2021)

Knowledge assessment regarding secondary prevention of coronary heart disease- a multi centre survey
por: Matthias, Anne Thushara, et al.
Publicado: (2014)

Using a standardized follow-up program to improve coronary heart disease secondary prevention
por: Gong, Yanjun, et al.
Publicado: (2016)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease
por: Müller-Riemenschneider, Falk, et al.
Publicado: (2009)

Systematic Review of the Effect of Diet and Exercise Lifestyle Interventions in the Secondary Prevention of Coronary Heart Disease
por: Cole, Judith A., et al.
Publicado: (2010)

Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease – A population-wide electronic cohort study
por: King, William, et al.
Publicado: (2018)

Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease
por: Jieni, Long, et al.
Publicado: (2021)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
por: Lin, Yahui, et al.
Publicado: (2022)

Retracted: High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients
por: Practice, Cardiology Research and
Publicado: (2023)

Extracorporeal Cardiac Shock Wave Therapy Ameliorates Clinical Symptoms and Improves Regional Myocardial Blood Flow in a Patient with Severe Coronary Artery Disease and Refractory Angina
por: Prinz, Christian, et al.
Publicado: (2009)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Is there a role for genetic risk assessment in the treatment of dyslipidemia in primary and secondary prevention of coronary heart disease?
por: Suwaidi, Jassim Al
Publicado: (2015)

Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland
por: Repo, Teppo, et al.
Publicado: (2018)

Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study
por: Kilic, Salih, et al.
Publicado: (2019)

Secondary Prevention in Patients with Coronary Heart Diseases: What Factors Are Associated with Health Status in Usual Primary Care?
por: Ose, Dominik, et al.
Publicado: (2012)

Comparing primary prevention with secondary prevention to explain decreasing Coronary Heart Disease death rates in Ireland, 1985–2000
por: Kabir, Zubair, et al.
Publicado: (2007)

Sex differences in secondary preventive follow-up after coronary heart events
por: Kaldal, Anete, et al.
Publicado: (2023)

Closing gaps in medication taking for secondary prevention of coronary heart disease patients among US adults
por: Liu, Xiaowei, et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A(2) Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
por: Hatoum, Ida J., et al.
Publicado: (2010)

Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease
por: Liu, Junmeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_81h5j5nci2rpl5pbgfncg1s0c3